Title : The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics - Greig_2000_Acta.Neurol.Scand.Suppl_176_74 |
Author(s) : Greig NH , De Micheli E , Holloway HW , Yu QS , Utsuki T , Perry TA , Brossi A , Ingram DK , Deutsch J , Lahiri DK , Soncrant TT |
Ref : Acta Neurologica Scandinavica Supplementum , 176 :74 , 2000 |
Abstract : |
PubMedSearch : Greig_2000_Acta.Neurol.Scand.Suppl_176_74 |
PubMedID: 11261809 |
Title : Neuroendocrine responses to intravenous infusion of physostigmine in patients with Alzheimer disease - Asthana_1999_Alzheimer.Dis.Assoc.Disord_13_102 |
Author(s) : Asthana S , Raffaele KC , Greig NH , Schapiro MB , Blackman MR , Soncrant TT |
Ref : Alzheimer Disease & Associated Disorders , 13 :102 , 1999 |
Abstract : |
PubMedSearch : Asthana_1999_Alzheimer.Dis.Assoc.Disord_13_102 |
PubMedID: 10372954 |
Title : Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease - Asthana_1995_Clin.Pharmacol.Ther_58_299 |
Author(s) : Asthana S , Greig NH , Hegedus L , Holloway HH , Raffaele KC , Schapiro MB , Soncrant TT |
Ref : Clinical Pharmacology & Therapeutics , 58 :299 , 1995 |
Abstract : |
PubMedSearch : Asthana_1995_Clin.Pharmacol.Ther_58_299 |
PubMedID: 7554703 |
Title : Sustained cortical metabolic responsivity to physostigmine after nucleus basalis magnocellularis ablation in rats - De Micheli_1993_Brain.Res_615_80 |
Author(s) : De Micheli E , Lamour Y , Bassant MH , Soncrant TT |
Ref : Brain Research , 615 :80 , 1993 |
Abstract : |
PubMedSearch : De Micheli_1993_Brain.Res_615_80 |
PubMedID: 8364728 |
Title : Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases - Atack_1989_J.Pharmacol.Exp.Ther_249_194 |
Author(s) : Atack JR , Yu QS , Soncrant TT , Brossi A , Rapoport SI |
Ref : Journal of Pharmacology & Experimental Therapeutics , 249 :194 , 1989 |
Abstract : |
PubMedSearch : Atack_1989_J.Pharmacol.Exp.Ther_249_194 |
PubMedID: 2709330 |